Clinical Report: Immunologic Profiles at Admission in Pediatric Patients with Mycoplasma pneumoniae Pneumonia

Overview

This study analyzes the immunologic profiles of pediatric patients with Mycoplasma pneumoniae pneumonia (MPP) at admission, focusing on molecular load and antibody titers. It identifies three distinct immunologic patterns based on admission-time molecular load and antibody response.

Background

Mycoplasma pneumoniae is a significant cause of community-acquired pneumonia in children, leading to numerous hospitalizations. Understanding the relationship between molecular load and antibody response is important in pediatric patients with MPP.

Data Highlights

Key Findings

• Among 402 children, 39.3% had MP-only pneumonia.
• MP + viral co-detection was linked to younger age and higher antibody titers.
• Antibody titers showed a timing-related gradient with higher titers corresponding to longer onset-to-admission intervals.
• Three immunologic patterns were identified: high-load/seronegative, high-load/high-titer, and lower-load/high-titer.
• Increased fever duration and neutrophil-to-lymphocyte ratio were observed across the immunologic patterns.

Clinical Implications

The findings suggest that clinicians should consider both molecular load and antibody titers when assessing pediatric patients with MPP. Understanding these immunologic patterns may aid in contextualizing the patient's immune status and illness timing.

Conclusion

The study provides insights into the immunologic profiles of children with MPP at admission.

Related Resources & Content

1. Frontiers in Pediatrics, 2026 -- Commentary: Comment on "Comparative analysis of blood routine, C-reactive protein, and biochemical markers in children with Mycoplasma pneumoniae pneumonia and its coinfections"
2. Frontiers in Immunology, 2026 -- Profound immune suppression and exhaustion characterize refractory mycoplasma pneumoniae pneumonia in children
3. Frontiers in Pediatrics, 2026 -- Clinical characteristics and cytokine profiles for early prediction of severe Mycoplasma pneumoniae pneumonia in children: a prospective cohort study
4. NICE, 2025 -- Recommendations | Pneumonia: diagnosis and management | Guidance
5. Frontiers in Pediatrics — Clinical characteristics, predictive factors, and therapeutic outcomes of mycoplasma pneumoniae pneumonia with pleural effusion in children: a retrospective cohort study
6. Diagnostic Accuracy of Serological Tests for Mycoplasma pneumoniae Infections in Children with Pneumonia, Based on Symptom Onset
7. Comparative and clinical impact of targeted next-generation sequencing in pediatric pneumonia diagnosis and treatment
8. Recommendations | Pneumonia: diagnosis and management | Guidance | NICE